About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Chroma™
Sofra™
mRNA Vaccines
Autoimmune Disease
Clinical Trials
Publications
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Latest News
Filter by Year:
2021
2019
2018
2017
2016
21-Dec-2017
EOY Guidance on 2018 NOX66 Clinical Development Strategy
6-Dec-2017
NOX Open Briefing Corporate Presentation
4-Dec-2017
Compassionate use of NOX66 in Patients
27-Nov-2017
AGM Presentations
20-Nov-2017
Promising Interim Clinical Data for NOX66
6-Nov-2017
Results of Meeting
6-Nov-2017
EGM Presentations
3-Nov-2017
UNSW collaboration confirms drug designed for stroke victims
30-Oct-2017
Appendix 4C - quarterly
23-Oct-2017
Update - General Meeting Agenda
1
2
3
4
5
Next
